Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Language
English
Number of Articles
36
Abbreviation
ODRR
e-ISSN
2230-6161
Main Publisher
Dove Medical Press
Publisher
Informa UK Limited
Indian UGC
DOAJ (latest)
Description
This journal is dedicated to advancing the understanding and development of orphan drugs for rare diseases. It offers a platform for researchers and clinicians to share their findings on the science, clinical aspects, and regulatory issues surrounding orphan drug development. Topics covered include implementation science and intervention research, health policy, clinical care, and implementation science. The reviews will feature research into the treatment, diagnosis, and prevention of rare diseases.
Aimed at researchers, healthcare professionals, and policymakers, this journal provides valuable insights into the challenges and opportunities in the field of orphan drugs. The journal is focused on contributing to improved treatment and outcomes for individuals affected by rare conditions.
Authors are invited to submit their original research, reviews, and perspectives to enhance the understanding of orphan drugs. Details regarding submission guidelines and the journal's focus can be found on the official website.